Eric Victory is Vice President & Head for cardiovascular, renal, metabolic, and infectious diseases within the Partnering & Strategy group at MedImmune, the biologics R&D unit of AstraZeneca. He is responsible for the company’s pre-proof of concept externalization activities in CV/Renal/Metabolism & Microbial Sciences. Eric has successfully closed the acquisitions of Spirogen and Amplimmune, brought on Sanofi Pasteur as a partner, and led key agreements with Inovio Pharmaceuticals, Omnis Pharmaceuticals, the Danish Diabetes Academy, the Joslin Diabetes Center, Shionogi, Advaxis, Immunocore, ADC Therapeutics, and NGM Biopharmaceuticals.